FT-7075, New Phase 1 Clinical Trial - Advanced Prostate...

Advanced Prostate Cancer

20,993 members26,168 posts

FT-7075, New Phase 1 Clinical Trial

StePeteMN profile image
7 Replies

Hi everyone, has anyone heard or read anything about FT-7075 from Forma Therapeutics? They have a new trial commencing for late-line patients and those with "AR-v7 splice variants". Here's the company's web page for the therapy... formatherapeutics.com/progr... and the US government info at clinicaltrials.gov/ct2/show... .

It's nice to see some possible-future hope as we try our best to kick the can down the road.

Written by
StePeteMN profile image
StePeteMN
To view profiles and participate in discussions please or .
Read more about...
7 Replies
Tall_Allen profile image
Tall_Allen

It's one of many BET inhibitors now in clinical trials. It targets a part of the the proteins (the "bromodomain") needed for cancer cell proliferation. The hope is that they will help androgen receptor therapies work better and longer, and it may increase the immunogenicity of prostate cancer. I hope it works for you!

StePeteMN profile image
StePeteMN in reply to Tall_Allen

I'm not eligible for the trial but wish them success!

wpopomaronis profile image
wpopomaronis in reply to Tall_Allen

Does it work on AR positive and AR negative patients? I’m negative and I am eligible for the trial but I don’t want to waste my time what are your thoughts my friend :-) The doctor seems to think it won’t make a difference!

Tall_Allen profile image
Tall_Allen in reply to wpopomaronis

It only works on those who express the AR. How did you determine that you are AR negative? You would only know that from an IHC analysis of a metastasis. You would not express PSA or PSMA if you are AR negative. Do you mean you are castration resistant?

wpopomaronis profile image
wpopomaronis in reply to Tall_Allen

I was told by by the urologist that I am AR negative. I definitely express PSMA since I was PSMA avid thereby allowing me to participate in the Lutetium trial. I am castrate resistant for sure. Thanks for trying to help me through this. The oncologist at the University of Maryland thinks it will help me his name is Dr. Arif Hussain.

Tall_Allen profile image
Tall_Allen in reply to wpopomaronis

Unless they did an IHC, you are not AR negative. That is a rare condition. Please get confirmation of that from your oncologist. It makes a big difference in whether a BET inhibitor can help you.

wpopomaronis profile image
wpopomaronis

I’ve been fighting this for 13 years and I’ve exhausted all traditional therapies. I am understanding that manny become AR positive over time. I was on Zytiga and that lasted for about a year and a half. Followed up with Xtandi and that lasted for about three months. So I just don’t know what’s going to happen. Had taxotere , 12 doses. That tore me up but it did lower my PSA consistently after each dose. What are your thoughts sir!

You may also like...

Embark Phase 3 clinical trial

Came across this today ---...

I-131-MIP-1095, a new radiopharmaceutical, will enter a phase 2 randomized clinical trial

winner, or if some combination turns out to be best....

New Drug BAY1841788 (ODM-201) has been successful for CRPC patients, Clinical trial Phase III completed.

for patients with Castration Resistance Prostate Cancer , apparently the clinical trial...

New Phase 1b (NON-randomized, dose timing) trial of Lu-177-PSMA-617 + Keytruda at UCSF announced

recruiting this month. Here are the details: https://clinicaltrials.gov/ct2/show/NCT03805594 Also,...

New article on Olaparib and Abiraterone Phase 2 trial - patient reported responses

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00498-3/fulltext?dgcid=raven_jbs_